Kanion is one of the China largest pharmaceutical companies. It intended to raise funds to expand the company plant extracts capacity recently. According to Herbridge Media, the company would invest ￥324 million for 1,500 tons of plant extract production project in order to expand the production scale of plant extracts, Kanion hope increase market shares and enhance market competitiveness.
Kanion told herbridge media, plant extracts are the essential raw materials of main TCM injections products, such as Re Du Ning and ginkgo terpene lactones injection. One of the important injections in the company is ginkgolide which has more than 10 years of R & D,now it has got the production approval in China,it's expected to market in the mid of 2013 at the earliest. At present,the market of ginkgo biloba products gradually expands,its profit margins is very considerable.
Copyright：Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
